180 related articles for article (PubMed ID: 34531077)
1. Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
Mkopi A; Mtenga S; Festo C; Mhalu G; Shabani J; Tillya R; Masemo A; Kheir K; Nassor M; Mwengee W; Lyimo D; Masanja H
Vaccine; 2021 Oct; 39(41):6041-6049. PubMed ID: 34531077
[TBL] [Abstract][Full Text] [Related]
2. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
[TBL] [Abstract][Full Text] [Related]
4. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
Thangaraj JWV; Prosperi C; Kumar MS; Hasan AZ; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sarmah NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murherkar MV
PLoS One; 2024; 19(3):e0297385. PubMed ID: 38551928
[TBL] [Abstract][Full Text] [Related]
5. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
Newtonraj A; Vincent A; Selvaraj K; Manikandan M
Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
[TBL] [Abstract][Full Text] [Related]
6. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
Danovaro-Holliday MC; Rhoda DA; Lacoul M; Prier ML; Gautam JS; Pokhrel TN; Dixit SM; Rajbhandari RM; Bose AS
BMC Public Health; 2022 Feb; 22(1):221. PubMed ID: 35114969
[TBL] [Abstract][Full Text] [Related]
7. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
[TBL] [Abstract][Full Text] [Related]
8. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
[TBL] [Abstract][Full Text] [Related]
9. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study.
Rajkumari B; Keisam A; Haobam DS; Thounaojam T
Indian J Public Health; 2020; 64(2):173-177. PubMed ID: 32584301
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with non-uptake of measles-rubella vaccine second dose among children under five years in Mtwara district council, Tanzania, 2017.
Magodi R; Mmbaga EJ; Massaga J; Lyimo D; Mphuru A; Abade A
Pan Afr Med J; 2019; 33():67. PubMed ID: 31448029
[TBL] [Abstract][Full Text] [Related]
12. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
13. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
[TBL] [Abstract][Full Text] [Related]
14. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
15. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
Ismail A; Tabu C; Onuekwusi I; Otieno SK; Ademba P; Kamau P; Koki B; Ngatia A; Wainaina A; Davis R
Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151
[TBL] [Abstract][Full Text] [Related]
16. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET
J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256
[TBL] [Abstract][Full Text] [Related]
17. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
18. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
Thompson KM; Badizadegan ND
Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
[TBL] [Abstract][Full Text] [Related]
19. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
Abd Elaziz KM; Sabbour SM; Dewedar SA
Vaccine; 2010 Nov; 28(47):7563-8. PubMed ID: 20797454
[TBL] [Abstract][Full Text] [Related]
20. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
